Glenmede Trust CO Na Intercept Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $563 - $976	-23 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $1,074 - $2,116	23 New	23 $1,000
Q4 2017 Feb 15, 2018	SELL	$58.2 - $72.76 $640 - $800	-11 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $627 - $1,306	11	11 $0

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.